v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Jan. 31, 2026
Cash flows from operating activities:      
Net loss $ (1,511,930) $ (682,888)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation 345,000 277,500  
Amortization of debt discount 36,801  
Change in assets and liabilities:      
Prepaid expenses (40,884) (65,735)  
Other receivable 35,000 3,644  
Accounts payable and accrued expenses 225,689 46,367  
Accounts payable and accrued expenses - related party (35,613) 66,012  
Accrued interest 90,879 129,133  
Net cash used in operating activities (855,058) (225,967)  
Cash flows from financing activities:      
Proceeds from convertible notes payable 1,255,000  
Proceeds from note payable 25,000  
Proceeds from notes payable to related party 100,000  
Repayment of debenture (250,000)  
Proceeds from exercise of warrants 108,000  
Repayment of notes payable (110,000)  
Net cash provided by financing activities 995,000 133,000  
Net (decrease) increase in cash 139,942 (92,967)  
Cash at beginning of period 24,274 100,678 $ 100,678
Cash at end of period 164,216 7,711 $ 24,274
Cash paid for interest 37,814 11,785  
Cash paid for taxes  
Non-cash investing and financing activities:      
Conversion of notes payable and accrued interest into convertible notes payable 102,947  
Issuance of warrants for convertible notes payable 780,854  
Deferred offering costs $ 133,082